Cargando…

P1399: INITIAL CLINICAL RESULTS OF EUPLAGIA-1, A PHASE 1/2 TRIAL OF POINT-OF-CARE MANUFACTURED GLPG5201 IN R/R CLL/SLL WITH OR WITHOUT RICHTER’S TRANSFORMATION

Detalles Bibliográficos
Autores principales: Martinez-Cibrian, Nuria, Betriu, Sergi, Ortiz-Maldonado, Valentín, Esteban, Daniel, Tovar, Natalia, Triguero Moreno, Ana, Alserawan, Leticia, Montoro, Mercedes, Van Muyden, Anna, Spoon, Maike, Pont, Margot, Jacques, Christian, Delgado, Julio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430544/
http://dx.doi.org/10.1097/01.HS9.0000972484.02679.4e
_version_ 1785090989650608128
author Martinez-Cibrian, Nuria
Betriu, Sergi
Ortiz-Maldonado, Valentín
Esteban, Daniel
Tovar, Natalia
Triguero Moreno, Ana
Alserawan, Leticia
Montoro, Mercedes
Van Muyden, Anna
Spoon, Maike
Pont, Margot
Jacques, Christian
Delgado, Julio
author_facet Martinez-Cibrian, Nuria
Betriu, Sergi
Ortiz-Maldonado, Valentín
Esteban, Daniel
Tovar, Natalia
Triguero Moreno, Ana
Alserawan, Leticia
Montoro, Mercedes
Van Muyden, Anna
Spoon, Maike
Pont, Margot
Jacques, Christian
Delgado, Julio
author_sort Martinez-Cibrian, Nuria
collection PubMed
description
format Online
Article
Text
id pubmed-10430544
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104305442023-08-17 P1399: INITIAL CLINICAL RESULTS OF EUPLAGIA-1, A PHASE 1/2 TRIAL OF POINT-OF-CARE MANUFACTURED GLPG5201 IN R/R CLL/SLL WITH OR WITHOUT RICHTER’S TRANSFORMATION Martinez-Cibrian, Nuria Betriu, Sergi Ortiz-Maldonado, Valentín Esteban, Daniel Tovar, Natalia Triguero Moreno, Ana Alserawan, Leticia Montoro, Mercedes Van Muyden, Anna Spoon, Maike Pont, Margot Jacques, Christian Delgado, Julio Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430544/ http://dx.doi.org/10.1097/01.HS9.0000972484.02679.4e Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Martinez-Cibrian, Nuria
Betriu, Sergi
Ortiz-Maldonado, Valentín
Esteban, Daniel
Tovar, Natalia
Triguero Moreno, Ana
Alserawan, Leticia
Montoro, Mercedes
Van Muyden, Anna
Spoon, Maike
Pont, Margot
Jacques, Christian
Delgado, Julio
P1399: INITIAL CLINICAL RESULTS OF EUPLAGIA-1, A PHASE 1/2 TRIAL OF POINT-OF-CARE MANUFACTURED GLPG5201 IN R/R CLL/SLL WITH OR WITHOUT RICHTER’S TRANSFORMATION
title P1399: INITIAL CLINICAL RESULTS OF EUPLAGIA-1, A PHASE 1/2 TRIAL OF POINT-OF-CARE MANUFACTURED GLPG5201 IN R/R CLL/SLL WITH OR WITHOUT RICHTER’S TRANSFORMATION
title_full P1399: INITIAL CLINICAL RESULTS OF EUPLAGIA-1, A PHASE 1/2 TRIAL OF POINT-OF-CARE MANUFACTURED GLPG5201 IN R/R CLL/SLL WITH OR WITHOUT RICHTER’S TRANSFORMATION
title_fullStr P1399: INITIAL CLINICAL RESULTS OF EUPLAGIA-1, A PHASE 1/2 TRIAL OF POINT-OF-CARE MANUFACTURED GLPG5201 IN R/R CLL/SLL WITH OR WITHOUT RICHTER’S TRANSFORMATION
title_full_unstemmed P1399: INITIAL CLINICAL RESULTS OF EUPLAGIA-1, A PHASE 1/2 TRIAL OF POINT-OF-CARE MANUFACTURED GLPG5201 IN R/R CLL/SLL WITH OR WITHOUT RICHTER’S TRANSFORMATION
title_short P1399: INITIAL CLINICAL RESULTS OF EUPLAGIA-1, A PHASE 1/2 TRIAL OF POINT-OF-CARE MANUFACTURED GLPG5201 IN R/R CLL/SLL WITH OR WITHOUT RICHTER’S TRANSFORMATION
title_sort p1399: initial clinical results of euplagia-1, a phase 1/2 trial of point-of-care manufactured glpg5201 in r/r cll/sll with or without richter’s transformation
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430544/
http://dx.doi.org/10.1097/01.HS9.0000972484.02679.4e
work_keys_str_mv AT martinezcibriannuria p1399initialclinicalresultsofeuplagia1aphase12trialofpointofcaremanufacturedglpg5201inrrcllsllwithorwithoutrichterstransformation
AT betriusergi p1399initialclinicalresultsofeuplagia1aphase12trialofpointofcaremanufacturedglpg5201inrrcllsllwithorwithoutrichterstransformation
AT ortizmaldonadovalentin p1399initialclinicalresultsofeuplagia1aphase12trialofpointofcaremanufacturedglpg5201inrrcllsllwithorwithoutrichterstransformation
AT estebandaniel p1399initialclinicalresultsofeuplagia1aphase12trialofpointofcaremanufacturedglpg5201inrrcllsllwithorwithoutrichterstransformation
AT tovarnatalia p1399initialclinicalresultsofeuplagia1aphase12trialofpointofcaremanufacturedglpg5201inrrcllsllwithorwithoutrichterstransformation
AT trigueromorenoana p1399initialclinicalresultsofeuplagia1aphase12trialofpointofcaremanufacturedglpg5201inrrcllsllwithorwithoutrichterstransformation
AT alserawanleticia p1399initialclinicalresultsofeuplagia1aphase12trialofpointofcaremanufacturedglpg5201inrrcllsllwithorwithoutrichterstransformation
AT montoromercedes p1399initialclinicalresultsofeuplagia1aphase12trialofpointofcaremanufacturedglpg5201inrrcllsllwithorwithoutrichterstransformation
AT vanmuydenanna p1399initialclinicalresultsofeuplagia1aphase12trialofpointofcaremanufacturedglpg5201inrrcllsllwithorwithoutrichterstransformation
AT spoonmaike p1399initialclinicalresultsofeuplagia1aphase12trialofpointofcaremanufacturedglpg5201inrrcllsllwithorwithoutrichterstransformation
AT pontmargot p1399initialclinicalresultsofeuplagia1aphase12trialofpointofcaremanufacturedglpg5201inrrcllsllwithorwithoutrichterstransformation
AT jacqueschristian p1399initialclinicalresultsofeuplagia1aphase12trialofpointofcaremanufacturedglpg5201inrrcllsllwithorwithoutrichterstransformation
AT delgadojulio p1399initialclinicalresultsofeuplagia1aphase12trialofpointofcaremanufacturedglpg5201inrrcllsllwithorwithoutrichterstransformation